Relation between asymmetric dimethylarginine (ADMA) and hearing loss in patients with renal impairment.
D000328:Adult; D001120:Arginine / Q000031:analogs & derivatives* / Q000097:blood; D002097:C-Reactive Protein / Q000378:metabolism; D016022:Case-Control Studies; D003404:Creatinine / Q000097:blood; D005260:Female; D006319:Hearing Loss, Sensorineural / Q000097:blood* / Q000175:diagnosis / Q000209:etiology*; D006801:Humans; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D051436:Renal Insufficiency, Chronic / Q000097:blood* / Q000150:complications* / Q000628:therapy; D012307:Risk Factors
D008055:Lipids; C018524:N,N-dimethylarginine; D002097:C-Reactive Protein; D001120:Arginine; D003404:Creatinine